Cingulate Inc. Contracts & Agreements
85 Contracts & Agreements
- Business Finance (53 contracts)
- Business Operations (4)
- Human Resources (21)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Uncategorized (5)
- Form of Inducement Letter (Filed With SEC on July 1, 2024)
- Form of Placement Agent Warrant (Filed With SEC on July 1, 2024)
- Amendment No. 1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (Filed With SEC on June 12, 2024)
- Form of March 2024 WFIA Pre-Funded Warrant (Filed With SEC on April 1, 2024)
- Description of Cingulate Inc. Securities (Filed With SEC on April 1, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on February 7, 2024)
- Form of Placement Agent Warrant (Filed With SEC on February 7, 2024)
- Form of Series B Warrant (Filed With SEC on February 7, 2024)
- Form of Series A Warrant (Filed With SEC on February 7, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 7, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 29, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 29, 2024)
- Note Conversion Agreement, dated January 25, 2024, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on January 29, 2024)
- Employment Agreement, dated January 25, 2024, between Cingulate Therapeutics LLC, and Jennifer L. Callahan (Filed With SEC on January 29, 2024)
- Form of Pre-Funded Warrant offered hereby (Filed With SEC on January 29, 2024)
- Form of Series A Warrant offered hereby (Filed With SEC on January 29, 2024)
- Form of Series B Warrant offered hereby (Filed With SEC on January 29, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 29, 2024)
- Amendment to Employment Agreement, effective December 29, 2023, between Cingulate Therapeutics, LLC and Raul A. Silva (Filed With SEC on January 12, 2024)
- Amendment to Employment Agreement, effective January 1, 2024, between Cingulate Therapeutics, LLC and Matthew N. Brams (Filed With SEC on January 12, 2024)
- Note Conversion Agreement, dated September 8, 2023, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on September 11, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on September 11, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on September 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2023)
- Form of Placement Agent Warrant (Filed With SEC on August 29, 2023)
- Form of Series B Warrant offered hereby (Filed With SEC on August 29, 2023)
- Form of Series A Warrant offered hereby (Filed With SEC on August 29, 2023)
- Form of Pre-Funded Warrant offered hereby (Filed With SEC on August 29, 2023)
- Form of Pre-Funded Warrant offered hereby (Filed With SEC on August 22, 2023)
- Form of Underwriting Agreement (Filed With SEC on August 22, 2023)
- Form of Series A Warrant offered hereby (Filed With SEC on August 22, 2023)
- Form of Series B Warrant offered hereby (Filed With SEC on August 22, 2023)
- Form of Underwriter Warrant (Filed With SEC on August 22, 2023)
- Securities Purchase Agreement, dated August 11, 2023, by and between the Company and Werth Family Investment Associates LLC (Filed With SEC on August 14, 2023)
- Amended and Restated Promissory Note, dated May 9, 2023, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on May 10, 2023)
- Amendment to ATM Agreement, dated May 2, 2023, by and between Cingulate Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 10, 2023)
- Registration Rights Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on April 25, 2023)
- Purchase Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on April 25, 2023)
- Joint Commercialization Agreement, dated March 7, 2023, by and between Cingulate Therapeutics, LLC and Indegene, Inc (Filed With SEC on March 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 10, 2023)
- Form of Pre-Funded Warrant to be offered hereby (Filed With SEC on March 10, 2023)
- Form of Warrant to be offered hereby (Filed With SEC on March 10, 2023)
- Form of Placement Agency Agreement (Filed With SEC on March 10, 2023)
- Amendment to Employment Agreement, effective January 1, 2023, between Cingulate Therapeutics LLC and Raul R. Silva (Filed With SEC on March 10, 2023)
- Master Services Agreement between Cingulate Therapeutics LLC and Societal CDMO, Inc., dated October 24, 2022 (Filed With SEC on October 25, 2022)
- Promissory Note, dated August 9, 2022, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on August 11, 2022)
- Amendment to Employment Agreement, effective April 1, 2022, between Cingulate Therapeutics LLC and Raul R. Silva (Filed With SEC on August 11, 2022)
- Form of Incentive Stock Option Award under 2021 Plan (Filed With SEC on May 12, 2022)
- Form of Nonqualified Stock Option Award under 2021 Plan (Filed With SEC on May 12, 2022)
- Description of Cingulate Inc. Securities (Filed With SEC on March 28, 2022)
- Form of Warrant (Filed With SEC on November 30, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 30, 2021)
- Form of Warrant Agency Agreement (Filed With SEC on November 30, 2021)
- Form of Underwriter Warrant (Filed With SEC on November 10, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 10, 2021)
- Form of Underwriting Agreement (Filed With SEC on October 1, 2021)
- Employment Agreement, dated September 23, 2021, between Cingulate Therapeutics LLC and Laurie A. Myers (Filed With SEC on September 27, 2021)
- Cingulate Inc. 2021 Omnibus Incentive Plan (Filed With SEC on September 27, 2021)
- Employment Agreement, dated September 23, 2021, between Cingulate Therapeutics LLC and Shane J. Schaffer (Filed With SEC on September 27, 2021)
- Employment Agreement, dated September 23, 2021, between Cingulate Therapeutics LLC and Matthew N. Brams (Filed With SEC on September 27, 2021)
- Employment Agreement, dated September 23, 2021, between Cingulate Therapeutics LLC and Craig S. Gilgallon (Filed With SEC on September 27, 2021)
- Employment Agreement, dated September 23, 2021, between Cingulate Therapeutics LLC and Louis G. Van Horn (Filed With SEC on September 27, 2021)
- Form of Nonqualified Stock Option Award under 2021 Plan (Filed With SEC on September 27, 2021)
- Employment Agreement, dated September 23, 2021, between Cingulate Therapeutics LLC and Raul R. Silva (Filed With SEC on September 27, 2021)
- Form of Incentive Stock Option Award under 2021 Plan (Filed With SEC on September 27, 2021)
- Form of Restricted Stock Unit Award under 2021 Plan (Filed With SEC on September 27, 2021)
- Form of Restricted Stock Award under 2021 Plan (Filed With SEC on September 27, 2021)
- Specimen Certificate representing shares of common stock of Cingulate Inc (Filed With SEC on September 9, 2021)
- Patent and Know-How License Agreement, dated August 8, 2018, between BDD Pharma Limited, Cingulate Therapeutics LLC and Drug Delivery International Limited (Filed With SEC on September 9, 2021)
- Master Services Agreement, dated August 20, 2018, by and between Pharmaceutical Manufacturing Research Services, Inc. and Cingulate Therapeutics LLC (Filed With SEC on September 9, 2021)
- Employment Agreement, dated January 1, 2021, between Cingulate Works Inc. and Shane J. Schaffer (Filed With SEC on September 9, 2021)
- Employment Agreement, dated January 1, 2021, between Cingulate Works Inc. and Matthew N. Brams (Filed With SEC on September 9, 2021)
- Employment Agreement, dated January 1, 2021, between Cingulate Works Inc. and Laurie A. Myers (Filed With SEC on September 9, 2021)
- Employment Agreement, dated January 1, 2021, between Cingulate Works Inc. and Craig S. Gilgallon (Filed With SEC on September 9, 2021)
- Employment Agreement, dated January 1, 2021, between Cingulate Works Inc. and Louis G. Van Horn (Filed With SEC on September 9, 2021)
- Employment Agreement, dated January 1, 2021, between Cingulate Works Inc. and Raul R. Silva (Filed With SEC on September 9, 2021)
- Form of Indemnification Agreement to be entered into by Cingulate Inc. with its Officers and Directors (Filed With SEC on September 9, 2021)
- Promissory Note, dated February 26, 2020, between Matthew Brams and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated September 30, 2020, between Matthew Brams and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Amendment to Notes, dated April 28, 2021, between Matthew Brams and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated July 25, 2020, between Raul Silva and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Amendment to Note, dated April 19, 2021, between Raul Silva and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated February 1, 2020, between Dresch Inc. and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Amendment to Note, dated May 20, 2021, between Dresch Inc. and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Agreement and Plan of Merger, dated August 30, 2021, among Cingulate, Inc., Cingulate Therapeutics LLC, and Cingulate Pharma LLC (Filed With SEC on September 9, 2021)
